Search results for: 'mrna fuel developed deceleration'

This Frost & Sullivan analysis provides an outlook for the electric vehicle (EV) industry based on the latest industry data, an outline of current trends, an in-depth examination of future developments, and a breakdown of the main stakeholders in the sector and their performance. EV sales in 2023 amounted to a total of 14.1 million, of which 70....

27 Oct 2021  |  Asia Pacific  |  Frost Radar

Frost Radar™ for Economic Development: Broader Asia, 2021

Australia, South Korea, and New Zealand Emerge as the Broader Asian Leaders

Infographics

×

Key Issues Addressed

The Frost Radar™ for Economic Development determines a region's future growth and development potential measured by its ability to enhance citizen satisfaction of quality of life. This report explores Broader Asia’s strengths and weaknesses through country-level assessments of growth and innovation initiatives and benchmarks each country on these t...

The alternative fuels sector is entering a critical phase where execution, not ambition, determines leadership. Success hinges first on overcoming legacy cultural constraints, enabling faster decision-making, experimentation, and partnership-led innovation. At the same time, firms must standardize regulatory intelligence to navigate fragmented poli...

RNA therapeutics is a rapidly expanding field of next-generation medicine. RNA therapy typically comprises 4 different classes of molecules: non-codingRNA (ncRNA), antisense oligonucleotide (ASO), messengerRNA (mRNA), and RNA aptamer. Small ncRNAs are like a double-edged sword; they can either up- or down-regulate specific genes. Contrarily, long...

Electronic devices are an integral part of human life, serving a multitude of functionalities. Many application areas for example, electronic gadgets, health monitoring and medical devices, activity tracking, smart cards, and wearable electronics require lightweight, flexible, and compact energy storage solutions. The focus on miniaturization and c...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

This edition of the Industrial Bioprocessing TOE features information on innovations in microbial fermentation, renewable fuels, oilseed production via extraction, direct air capture, low carb fuels, battery recycling, and plastic upcycling, among others.The Industrial Bioprocessing TOE provides intelligence on technologies, processes and strategic...

Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

The analysis explores the global passenger fuel cell electric vehicle (FCEV) ecosystem, delving into emerging industry growth and consumer demand trends, supportive government policies, and technological advancements. By scrutinizing sales industry data and forecasts, we aim to discern patterns indicative of FCEV adoption worldwide. Our explorat...